scholarly journals Evaluation of Molecular Epidemiology, Clinical Characteristics, Antifungal Susceptibility Profiles, and Molecular Mechanisms of Antifungal Resistance of Iranian Candida parapsilosis Species Complex Blood Isolates

Author(s):  
Amir Arastehfar ◽  
Farnaz Daneshnia ◽  
Mohammad Javad Najafzadeh ◽  
Ferry Hagen ◽  
Shahram Mahmoudi ◽  
...  
Author(s):  
Engin Kaplan ◽  
Ayşe Sultan Karakoyun ◽  
Deniz Alkaya ◽  
Nevzat Ünal ◽  
Aylin Döğen ◽  
...  

Objective: Candida parapsilosis species complex and Lodderomyces elongisporus may have differences in terms of their virulence, prevalence, and antifungal susceptibility profiles. These species are difficult to identify with biochemical methods. Therefore, there is a need for more efficient identification methods in terms of time, cost, and applicability. This study aims to evaluate the diagnostic performance of the MALDI-TOF MS method in discriminating between isolates belonging to the C. parapsilosis species complex and L. elongisporus. Method: In the current study, a total of 32 reference strains, including the C. parapsilosis (n=8), Candida orthopsilosis (n=7), Candida metapsilosis (n=6), and L. elongisporus (n=11) species were identified using the MALDI-TOF MS method. Results: The species names of 31 (93.7%) isolates belonging to the C. parapsilosis species complex and L.elongisporus were correctly identified. Twenty four isolates including eight (100%) C. parapsilosis, five (83%) C. metapsilosis, five (71%) C. orthopsilosis, and six (54%) L. elongisporus isolates were identified with score values ranging from 1.7 to 2.14. According to the secure identification reference score of ≥ 1.7, the sensitivity and specificity of the MALDI-TOF MS method were determined as 54.5–100% and 96.3–100%, respectively. Conclusion: Although the MALDI-TOF MS method has been shown to be effective in the rapid molecular phenotypic diagnosis of species that were difficult to discriminate using biochemical methods such as C. parapsilosis species complex and L. elongisporus, there is a clear need to optimize the method and develop a larger MS library for species-level identification within secure score ranges.


2020 ◽  
Vol 69 (1) ◽  
pp. 72-81 ◽  
Author(s):  
Zainab Bandalizadeh ◽  
Tahereh Shokohi ◽  
Hamid Badali ◽  
Mahdi Abastabar ◽  
Farhang Babamahmoudi ◽  
...  

2017 ◽  
Vol 34 (2) ◽  
pp. 106-108 ◽  
Author(s):  
Débora de Souza Olartechea de Alencar ◽  
Rosianne Assis de Sousa Tsujisaki ◽  
Fernanda Luiza Espinosa Spositto ◽  
Maína de Oliveira Nunes ◽  
Adriana Araújo de Almeida ◽  
...  

2012 ◽  
Vol 61 (7) ◽  
pp. 1003-1008 ◽  
Author(s):  
Lucas Xavier Bonfietti ◽  
Marilena dos Anjos Martins ◽  
Maria Walderez Szeszs ◽  
Sandra Brasil Stolf Pukiskas ◽  
Sonia Ueda Purisco ◽  
...  

2018 ◽  
Vol 67 (7) ◽  
pp. 903-914 ◽  
Author(s):  
Raimunda Sâmia Nogueira Brilhante ◽  
Jamille Alencar Sales ◽  
Maria Lucilene Queiroz da Silva ◽  
Jonathas Sales de Oliveira ◽  
Lucas de Alencar Pereira ◽  
...  

2019 ◽  
Vol 32 (2) ◽  
Author(s):  
Renáta Tóth ◽  
Jozef Nosek ◽  
Héctor M. Mora-Montes ◽  
Toni Gabaldon ◽  
Joseph M. Bliss ◽  
...  

SUMMARYPatients with suppressed immunity are at the highest risk for hospital-acquired infections. Among these, invasive candidiasis is the most prevalent systemic fungal nosocomial infection. Over recent decades, the combined prevalence of non-albicans Candidaspecies outrankedCandida albicansinfections in several geographical regions worldwide, highlighting the need to understand their pathobiology in order to develop effective treatment and to prevent future outbreaks.Candida parapsilosisis the second or third most frequently isolatedCandidaspecies from patients. Besides being highly prevalent, its biology differs markedly from that ofC. albicans, which may be associated withC. parapsilosis’ increased incidence. Differences in virulence, regulatory and antifungal drug resistance mechanisms, and the patient groups at risk indicate that conclusions drawn fromC. albicanspathobiology cannot be simply extrapolated toC. parapsilosis. Such species-specific characteristics may also influence their recognition and elimination by the host and the efficacy of antifungal drugs. Due to the availability of high-throughput, state-of-the-art experimental tools and molecular genetic methods adapted toC. parapsilosis, genome and transcriptome studies are now available that greatly contribute to our understanding of what makes this species a threat. In this review, we summarize 10 years of findings onC. parapsilosispathogenesis, including the species’ genetic properties, transcriptome studies, host responses, and molecular mechanisms of virulence. Antifungal susceptibility studies and clinician perspectives are discussed. We also present regional incidence reports in order to provide an updated worldwide epidemiology summary.


2018 ◽  
Vol 95 ◽  
pp. 100-107 ◽  
Author(s):  
Katherine Miranda-Cadena ◽  
Cristina Marcos-Arias ◽  
Estibaliz Mateo ◽  
José Manuel Aguirre ◽  
Guillermo Quindós ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document